other material
confidence high
sentiment neutral
materiality 0.65
Nuvectis Pharma prices $16M underwritten offering of 3.2M shares at $5.00; effects 39-for-1 stock split
Nuvectis Pharma, Inc.
- Gross proceeds of $16M from sale of 3.2M shares at $5.00; expected close Feb 8, 2022.
- 39-for-1 stock split effective Feb 3, 2022; shares begin trading split-adjusted Feb 4, 2022.
- Authorized common stock increased to 60M shares; authorized preferred stock at 5M shares.
- Underwriting agreement with H.C. Wainwright & Co. as representative of underwriters.